Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19
Phase 1
Recruiting
- Conditions
- COVID-19.COVID-19U07.1
- Registration Number
- IRCT20150808023559N20
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RT-PCR test for COVID-19
Requiring hospitalization
Patient's age between 16 and 100 years
Signed informed consent form
Exclusion Criteria
Receiving other antiviral medications
renal failure
Pregnancy
HIV
Lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death. Timepoint: At the time of discharge from the hospital. Method of measurement: Patient medical records.
- Secondary Outcome Measures
Name Time Method Hospital stay. Timepoint: End of intervention. Method of measurement: Patient medical records.